Influenza Diagnostics Market Size, Drivers, Restraints Challenges, and Growth Opportunities Till 2027

Influenza Diagnostics Market is valued at USD 558.1 Million in 2019 and expected to reach USD 907.9 Million by 2026 with the CAGR of 7.2% over the forecast period"Global Influenza Diagnostics Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2020-2026- Increasing prevalence of infectious diseases, seasonal influenza and the growing research and development activities are some of the major factors driving the growth of Global Influenza Diagnostics Market.Scope of Global Influenza Diagnostics Market Report-Influenza is an acute respiratory tract infection (ARTI) also known as flu with a nurture period ranging from 1 to 4 days.

It is an infectious disease caused by the influenza virus.

There are four types of seasonal influenza viruses, types A, B, C and D. Among all, Influenza A and B viruses circulate and cause seasonal epidemics of disease.

Based upon test type, influenza diagnostics market is classified into reverse transcription polymerase chain reaction (RT-PCR), rapid antigen testing, cell culture and others (immunofluorescence & serology).

Based upon end-user, influenza diagnostics market is classified into hospitals, research centers, diagnostic laboratories, and point of care testing centers (POCT).The regions covered in this influenza diagnostics market report are North America, Europe, Asia-Pacific and Rest of the World.

On the basis of country level, market of influenza diagnostics is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.Key Players of Influenza Diagnostics -Influenza diagnostics market report covers prominent players are Roche Diagnostics, Princeton BioMedtech corp, Meridian Bioscience, Inc, Becton Dickinson and Company Sekisui Diagnostics, Thermo Fisher Scientific.

Rapid influenza diagnostic market tests (RIDTs) are type of immunoassays which identifies the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens.

The RIDTs have received attention as it offers advantages over the other methods, for instance rapid result in less than approximately 15 minutes, high specificity and easy performance.

According to Centers for Disease Control and Prevention 2017 estimation, every year approximately 291,000 and 646,000 people die from seasonal influenza-related respiratory illness globally.Rapid influenza diagnostics market is expected to rise with a substantial CAGR in the forecast period of 2019-2026.

This rise in market value can be attributed to the rising number of geriatric population.This Rapid influenza diagnostics market report studies and analyses facts and figures about the market segmentation very carefully and represent it in the form of graphs for the better understanding of end user.

It not only identifies the emerging trends along with major drivers, challenges and opportunities in the market but also analyses them efficiently.

The market report has been specially designed by keeping in mind the customer requirements with which businesses can get assistance in increasing their return on investment (ROI).

JULY 20, 2020: The U.S.

Influenza Diagnostics market size is expected to reach USD 166.0 million by the year 2026 growing at a CAGR of 5.4% according to a new report by Grand View Research, Inc. Key drivers of the market include rising disease prevalence, increase in geriatric population and high-risk population for influenza such as children, pregnant women and immunosuppressed patients suffering from various chronic diseases.The rise in the prevalence of the flu in the U.S. is expected to boost market growth.

Data from CDC indicates that flu incidence was relatively low in the months of October 2018 and November 2018, however, rise in the number of cases was witnessed in December 2018 and remained high until February 2019.

These facts are indicative of the rising prevalence of the flu, necessitating increasing demand for diagnostic products.To Request A Sample Copy Of This Report @:   https://www.radiantinsights.com/research/us-influenza-diagnostics-market/request-sampleAdditionally, individuals with a high risk of contracting the influenza virus consist of children, pregnant women, immunosuppressed patients suffering from chronic diseases and healthcare workers.

In addition, key participants are engaged in various inorganic and organic strategic developments to expand their existing product portfolios and geographic expansion.

This assay facilitates rapid detection of influenza B & A antigens by nasopharyngeal and nasal swab from patients.Hospitals held the largest market share in 2018 due to the rise in prevalence of flu.

Influenza Diagnostics Market:WiseGuyReports.com adds “Global Influenza Diagnostics Market Research Report 2020 Analysis and Forecast 2026” reports to its database.Executive SummaryGlobal Influenza Diagnostics Market is valued approximately at USD 646.5 million in 2019 and is anticipated to grow with a growth rate of more than 7.8% over the forecast period 2020-2026.

Influenza is an infectious respiratory infection caused via flu viruses.

Each year seasonal influenza affects millions of people leading thousands of hospitalizations and flu-related deaths.

Influenza outbreaks have encouraged healthcare authorities across the world to upsurge the capacity of influenza diagnosis, which is further contributing towards the adoption of influenza diagnostics.

Global influenza diagnostic market growth is mainly driven by aspects such as the growing incidence of influenza, growing in research funding for influenza diagnostics, and the growing demand for faster diagnosis.

Similarly, Quidel Corporation received FDA clearance for QuickVue Influenza A+B Test product.

The Business Research Company published its Influenza Diagnostic Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global influenza diagnostic market.

The report covers the influenza diagnostic market’s segments- by traditional diagnostic tests: rapid influenza diagnostic tests (RIDT), viral culture, DFA, serological assays, others, by molecular diagnostic tests: reverse transcription polymerase chain reaction (RT-PCR), isothermal nucleic acid amplification tests (INAAT), loop mediated isothermal based amplification assays, transcription mediated isothermal based amplification assays, transcription mediated isothermal based amplification assays, other isothermal nucleic acid amplification tests, other molecular diagnostic tests, and by end user: hospitals & clinical laboratories, diagnostic reference laboratories, academic/research institutes, other end users.View Complete Report: https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-market-global-report-2020-30-covid-19-implications-and-growthInfluenza Diagnostic Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.

The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country.

The major regions included in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.Rapid influenza diagnostic tests (RIDTs) are immunoassays which can identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens and display the result in a qualitative way (positive vs. negative).

It can yield results in a clinically relevant time frame of less than approximately 15 minutes and diagnose patients who are present with influenza-like illness.

This is mainly if it is performed within the first four days of the onset of symptoms.

Consistent with the report published by the experts, it is estimated that the global Influenza Diagnostics Market would develop at a substantial CAGR during the period of forecast.

Hence, by means of a growing number of persons being prone to the illness, the demand for influenza diagnostics products has been increasing and powering the development of the market.

Classification: The global influenza diagnostics market can be classified by End Use, Type of Test, and Region.

By End Use it can be classified asPOCT [Point Of Care Testing],Hospitals, and Laboratories.

The subdivision of Hospitals held the principal share during 2015.

But it is likely to decelerate gradually by way of the arrival of POCT laboratories that propose precise results.

Recently published a report entitled Influenza Diagnostics Market projected till 2026, added by Value Market Research, covers key players along with their market share and strategic development adopted by them.

Further, the report provides market size, share, trends, outlook and forecast based on historical data coupled with drivers, restraints, and opportunities.The broad influenza diagnostics market has been sub-grouped into test type and end-use.

The report studies these subsets with respect to the geographical segmentation.

The strategists can gain a detailed insight and devise appropriate strategies to target specific market.

This detail will lead to a focused approach leading to identification of better opportunities.Request a FREE Sample Copy of Influenza Diagnostics Market Report with Full TOC At: https://www.valuemarketresearch.com/contact/influenza-diagnostics-market/download-sampleBy Test TypeRIDTRT-PCRCell CultureOthersBy End-UseHospitalPOCTLaboratoriesThe report also covers detailed competitive landscape including company profiles of key players operating in the global market.

The key players in the influenza diagnostics market include 3M Health Care, Alere, Becton, Dickinson and Company (BD), Meridian Bioscience, Inc., Quidel Corporation, Roche Diagnostics Corporation, SA Scientific, Sekisui Diagnostics and Thermo Fisher Scientific, Inc. among others.